Calidi Biotherapeutics Inc CLDI

$0.62 -0.03 (-5.08%)

Valuation

Market cap
1,743,000
Revenue TTM
$0
Net income TTM
$-19,910,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
0.00%
Debt to equity
0.19

Trading

Volume
28,400
Avg volume
116,522
Day's range
$0.62 – $0.68
Shares out
2,660,000
Stochastic %K
1%
Beta
1.37
Analysts
—
Price target
$10.00

Price

Company profile

Calidi Biotherapeutics, Inc., a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease. The company offers CLD-101, which is in Phase 1b/2 clinical trial for the treatment of newly diagnosed high grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck c...

Show more

Calidi Biotherapeutics, Inc., a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease. The company offers CLD-101, which is in Phase 1b/2 clinical trial for the treatment of newly diagnosed high grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck cancer, and sarcoma; and CLD-401 for the treatment of metastatic solid tumors. It also offers oncolytic virus platforms, such as NeuroNova and SuperNova. Calidi Biotherapeutics, Inc. was founded in 2014 and is headquartered in San Diego, California.

Industry
Biotechnology
Sector
Healthcare
Phone
858 794 9600
Website
https://www.calidibio.com
Address
4475 Executive Drive, Suite 200, San Diego, United States

Latest news

Stocktwits

AXLFI_HQ Nov 14, 12:08 AM
$CLDI Micro-cap and shell-company financing strain, going-concern risk, dilution and balance-sheet repair dominate small-cap disclosures. Learn more: https://axlfi.com/themes/short/775
0 replies
race2zero Nov 13, 11:53 PM
$LABT that was scary for about 42 seconds, but right back to the .20s. Safest short other than $CLDI
0 replies
focafoca99 Nov 13, 9:57 PM
$CLDI announced its Q3 2026 financial results in a press release.
0 replies
race2zero Nov 13, 12:36 PM
$CLDI my bad, I’ve been so focused on $LABT i didn’t see you wander in here. Get out while you still can, one of the biggest penny bio scams around right here
0 replies
EkexBull Nov 12, 3:10 AM
$CLDI Positive pre-IND feedback for lead cancer-treatment candidate CLD-401.1
0 replies
NetworkNewsWire Nov 11, 8:45 PM
Study Discovers Possible Reason for Immunotherapy Not Working in Some Patients $CLDI #TinyGems #Immunotherapy https://ibn.fm/j5yPx
0 replies
NetworkNewsWire Nov 10, 7:58 PM
MIT Researchers Engineer Donor Immune Cells to Wipe Out Cancer Cells $CLDI https://ibn.fm/5uJ1f #biomedstocks #Cancer
0 replies
N0St0pL0ss Nov 6, 2:19 PM
$CLDI
0 replies